s6y

BRAINSTORM CELL THERAPEUTICS INC.

Ticker
BCLI
CIK
1137883
Industry
Biological Products, (No Diagnostic Substances)
Formerly
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC

Financials 87

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 87 financials filings

News 247

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 247 news filings

Ownership 372

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 372 ownership filings

Prospectus 94

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-1 General form of registration statement for all companies including face-amount certificate companies
  3. RW Registration Withdrawal Request
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-3 Registration statement for specified transactions by certain issuers
  6. S-3/A Registration statement for specified transactions by certain issuers
  7. S-3 Registration statement for specified transactions by certain issuers
  8. S-3 Registration statement for specified transactions by certain issuers
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 94 prospectus filings

Proxies 32

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. PRER14A Preliminary revised proxy soliciting materials
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 32 proxies filings

Other 119

  1. EFFECT Notice of Effectiveness
  2. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  3. UPLOAD Letter (PDF)
  4. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  5. ARS Annual report to security holders
  6. SCHEDULE 13G
  7. SCHEDULE 13G/A
  8. EFFECT Notice of Effectiveness
  9. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 119 other filings